Yki-Järvinen H, Dressler A, Ziemen M, for the HOE 901/3002 Study Group. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. Diabetes Care. 2000;23: 1130-1136.
3.
Skyler JS.Insulin treatment. In: Lebovitz HE, ed. Therapy for Diabetes Mellitus and Related Disorders. 3rd ed.Alexandria, Va: American Diabetes Association; 1998:186-203.
4.
Edelman SV, Henry RR.Insulin therapy for normalizing glycosylated hemoglobin in type II diabetes: application, benefits, and risks. Diabetes Rev.1995;3:308-334.
5.
Reaven GM, Hollen-beck C, Jeng CY, Wu MS, Chen YD.Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes. 1988;37: 1020-1024.
6.
Rosenstock J, Riddle MC, for the HOE 901/4002 Study Group. Treatment to target study: timing and frequency of nocturnal hypoglycemia. The value of adding bedtime basal insulin glargine over NPH insulin in insulin-naïve patients with type 2 diabetes on oral agents [abstract 1982-PO]. Diabetes. 2002; 51(suppl 2):A482.
7.
American Diabetes Association. Clinical practice recommendations 2002. Diabetes Care. 2002;25(suppl 1): S1-S147.
